
	As of		As Revised(2)
	June 30, 2026		December 31, 2025

Included in Condensed Consolidated Balance Sheets:
Cash	$	78,114	$	77,119
Accounts receivable	48,252		47,701
Inventory	204,504		195,184
Other current assets	34,918		37,369
Total current assets	365,788		357,373
Property, plant, and equipment , net	459,805		474,338
Right-of-use assets	222,324		201,434
Intangible assets, net and goodwill	1,303,607		1,343,581
Other long-term assets	17,783		15,454
Total assets	$	2,369,307	$	2,392,180

Accounts payable	$	44,194	$	57,622
Accrued expenses	65,570		88,060
Income tax payable(2)	5,337		14,218
Other current liabilities	54,380		49,178
Total current liabilities	169,481		209,078
Deferred tax liability(2)	81,622		163,433
Lease liabilities	256,158		239,223
Long-term financial obligation	195,431		202,901
Long-term debt(1)(2)	468,447		449,168
Uncertain tax position(2)	468,484		531,508
Other long-term liabilities	9,794		1,114
Total liabilities	$	1,649,417	$	1,796,425
Equity attributable to Curaleaf Holdings, Inc.	$	719,890	$	595,755

(1) In conjunction with the issuance of the Senior Secured Notes – 2026 in December 2021, the Company entered into an intercompany loan agreement with Curaleaf Inc. On February 18, 2026, the Senior Secured Notes – 2026 were repaid using proceeds from the issuance of the Senior Secured Notes – 2029. The intercompany loan remains outstanding, is reflected herein and has been eliminated in the condensed consolidated financial statements.
(2) The consolidated financial statements as of and for the year ended December 31, 2025 accurately reflect the correct accounting treatment of the Company's variable interest entities ("VIEs"). During the preparation of the Company's expanded VIE disclosures, management identified a classification difference in the VIE tabular disclosure above resulting from the incorrect allocation of certain tax-related balances between VIE and non-VIE entities. Management concluded that the difference was not material to the Company's consolidated financial statements. Accordingly, the VIE information as of December 31, 2025 has been revised to reflect the corrected allocation of balances between VIE and non-VIE entities, which (i) decreased income tax payable and total current liabilities by $287.6 million; (ii) increased deferred tax liabilities by $3.9 million, long-term debt by $1.2 million and uncertain tax positions by $271.9 million; (iii) resulted in a net decrease in total liabilities of $10.6 million; and (iv) increased equity attributable to Curaleaf Holdings, Inc. by $10.6 million and decreased net income attributable to Curaleaf Holdings, Inc. by $10.6 million.


			As Revised(1)				As Revised(1)
	Three months ended June 30,				Six months ended June 30,
	2026		2025		2026		2025
Included in Condensed Consolidated Statements of Operations:
Revenues, net	$	288,695	$	310,586	$	565,682	$	548,376
Net income (loss) attributable to Curaleaf Holdings, Inc.	32,295		(49,270)		112,098		(100,320)
(1) The consolidated financial statements for the three and six months ended June 30, 2025 accurately reflect the correct accounting treatment of the Company's VIEs. During the preparation of the Company's expanded VIE disclosures, management identified a classification difference in the VIE tabular disclosure above resulting from the incorrect allocation of certain tax-related balances between VIE and non-VIE entities. Management concluded that the difference was not material to the Company's consolidated financial statements. Accordingly, the VIE information for the three and six months ended June 30, 2025 has been revised to reflect the corrected allocation of balances between VIE and non-VIE entities, which decreased net loss attributable to Curaleaf Holdings, Inc. included in the VIE disclosure by $3.1 million for the three months ended June 30, 2025 and decreased net loss attributable to Curaleaf Holdings, Inc. by $8.6 million for the six months ended June 30, 2025.